Opens in a new tab

MED-EL v Advanced Bionics (CFI, 28 May 2025)

Date28 May 2025
CourtCFI
DivisionMannheim (DE) Local Division
Type of actionWithdrawal (RoP265)
Registry referenceApp_25220/2025 · ORD_25313/2025
PartiesMED-EL Elektromedizinische Geräte Gesellschaft m.b.H.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 28 May 2025, the Mannheim Local Division, following a settlement, permitted MED-EL Elektromedizinische Geräte to withdraw its infringement action on EP 4 074 373 against three Advanced Bionics companies (UPC_CFI_410/2023), cancelled the date set for pronouncing the decision and declared the proceedings closed. It refused any reimbursement of court fees, which were charged to the claimant, and set the value in dispute at EUR 6,000,000.

Question

Does a withdrawal made just before the pronouncement of a decision already drafted give rise to a partial reimbursement of court fees?

Decision

No. The division noted that the decision had been fully drafted and signed when the action was withdrawn and only remained to be uploaded, which the parties knew. It added that the parties had left it uncertain until the last moment whether the pronouncement date would stand and had responded only after directions from the Court. These were exceptional circumstances within Rule 370.9(e), which exclude the reimbursement provided for in Rule 370.9(b). The parties had waived any application for costs.

Key points for practice

Provisions applied

Rules of Procedure
Rules 265 and 370.9(b) and (e)

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Supplementary protection certificate (SPC), Biosimilar medicinal product, Launch at risk.

Dhenne Avocats blog: Pharmaceutical patents and the UPC: is the Court hostile to them?.

Publications by Matthieu Dhenne: The Launch Letter: How Generics and Biosimilars Should Write to Avoid UPC Urgency (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Withdrawal (RoP265)
Outcome (Dhenne Avocats summary)
La division autorise le désistement et clôt l'instance, mais refuse le remboursement des frais de justice, la décision étant déjà rédigée et signée et les parties ayant tardé à informer la Cour. Valeur du litige fixée à 6 000 000 euros.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 4 074 373
Mri-safe disk magnet for implants
recorded proprietor: MED EL Elektromedizinische Geraete GmbH
Mentioned in the analysis (role not qualified)
Also mentioned in 9 other decision(s): Advanced Bionics v MED-EL Elektromedizinische Geräte (CFI, 26 December · MED-EL Elektromedizinische Geräte v Zhejiang Nurotron Biotechnology (C · MED-EL Elektromedizinische Geräte v Zhejiang Nurotron Biotechnology (C · Advanced Bionics v MED-EL Elektromedizinische Geräte (CoA, 3 July 2025 · Advanced Bionics v MED-EL Elektromedizinische Geräte Gesellschaft m.b. · Advanced Bionics v MED-EL Elektromedizinische Geräte Gesellschaft m.b. · MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. v Advanced Bioni · Advanced Bionics v MED-EL Elektromedizinische Geräte (CFI, 15 April 20
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.